Regeneron: Scaling NGS to deliver more discoveries, faster
14 April 2017
Aris Baras and John Overton of Regeneron discuss their latest work and overall mission to explore new variations in genomes that can help explain disease. As one of the largest biotech companies in the world, Regeneron’s focus on large scale sequencing studies and finding mutations in certain genes is ultimately improving patient outcomes. Hear how they plan to utilize the NovaSeq™ 6000 System and why the introduction of this new technology is allowing them to redesign their experiments to take advantage of a whole new level of scale and output. View related videos CZ Biohub: Conducting innovative experiments with NGS
youtube.com/watch?v=RR4t5kZagkY Introducing NovaSeq: The Next Era in Sequencing Starts Now
youtube.com/watch?v=y7uqvGRRqEw View related webinars See the NovaSeq 6000 System in action
illuminainc.adobeconnect.com/p3jnyrp1t4d View related information NovaSeq 6000 System
illumina.com/novaseq Subscribe to the Illumina video channel
youtube.com/subscription_center?add_user=IlluminaInc For Research Use Only. Not for use in diagnostic procedures. A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. *Data calculations on file. Illumina, Inc., 2015. Subscribe to the Illumina video channel
youtube.com/subscription_center?add_user=IlluminaInc View customer spotlight videos
youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars
youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina product videos
youtube.com/playlist?list=PLKRu7cmBQlaj6YuZmkfxZcT9twqDgP2Xd View Illumina support videos
youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM